Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs
A Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in Federal Qualified Health Centers
H. Lee Moffitt Cancer Center and Research Institute
2,900 participants
Oct 10, 2025
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to examine how different messages about risk of skin cancer can impact the uptake of skin cancer prevention activities.
Eligibility
Inclusion Criteria6
- Be a patient of any race or ethnicity attending one of the six Tampa Family Health Centers.
- Be 18 years of age or older.
- Self-report skin cancer risk behaviors within the past 12 months, including: Intentional sun exposure (e.g., outdoor or indoor tanning) or unintentional sun exposure leading to sunburn.
- Be willing to complete a baseline questionnaire and provide a saliva sample for MC1R genotyping.
- Be able to provide informed consent (written or electronic).
- Prefer English or Spanish for communication and study materials.
Exclusion Criteria4
- Do not report any skin cancer risk behaviors (i.e., no tanning or sunburning in the past 12 months).
- Are unwilling or unable to complete the baseline assessment or return the saliva kit.
- Decline to provide informed consent.
- Are under 18 years of age.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Precision prevention booklet anchored in their MC1R risk that incorporates gold-standard risk communication strategies, including visual risk representations and simple language.
Standard materials are similar in content to the precision prevention booklet but without any reference to MC1R risk.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07222995